News

Health and Me on MSN3h
EU Approves 'Twice Yearly' Injectable HIV Drug To Fight The Virus And Stop Transmission
The EU has approved an injectable HIV drug offering a two-month dosage schedule, marking a breakthrough in treatment ...
TipRanks on MSN15h
Europe Grants Limited Approval to Eli Lilly’s (LLY) Alzheimer’s Drug
The European Medicines Agency (EMA) has granted limited approval to Eli Lilly’s (LLY) new Alzheimer’s drug Kisunla, reversing ...
Medscape19h
EMA Says No to Duchenne Gene Therapy Elevidys
The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.
News Tribune21h
EU regulator greenlights injectable HIV drug that could help stop transmission
The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which ...
Pharmabiz23h
Gilead receives positive CHMP opinions under accelerated review from EMA for twice-yearly lenacapavir for HIV prevention
Gilead receives positive CHMP opinions under accelerated review from EMA for twice-yearly lenacapavir for HIV prevention: Foster City, California Saturday, July 26, 2025, 13:00 Hr ...
EU Regulator Green Lights an Injectable HIV Drug That Could Help Stop Transmission
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...